Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $1,609,916 (100.0% shares, 0.0% debt)

Holdings (38)

Increased Positions (9)

Exited Positions (1)

Unchanged Positions (18)

WGS GENEDX HOLDINGS CORP 24.3%
Value ($000) $391,112 Shares 3,007,164 Est. Cost $9.11 Unrealized +1406.1%
MAZE MAZE THERAPEUTICS INC 2.0%
Value ($000) $31,439 Shares 758,857 Est. Cost $12.04 Unrealized +185.5%
PRME PRIME MEDICINE INC 0.7%
Value ($000) $10,990 Shares 3,167,175 Est. Cost $4.73 Unrealized -6.0%
TEM TEMPUS AI INC 1.1%
Value ($000) $17,368 Shares 294,127 Est. Cost $70.04 Unrealized +11.7%
BEAM BEAM THERAPEUTICS INC 2.8%
Value ($000) $44,352 Shares 1,600,000 Est. Cost $36.48 Unrealized -30.1%
SEPN SEPTERNA INC 1.0%
Value ($000) $15,425 Shares 553,268 Est. Cost $23.65 Unrealized +1.0%
NGNE NEUROGENE INC 1.7%
Value ($000) $26,684 Shares 1,295,361 Est. Cost $27.94 Unrealized -10.9%
SPRY ARS PHARMACEUTICALS INC 1.2%
Value ($000) $18,640 Shares 1,600,000 Est. Cost $14.35 Unrealized -32.2%
VCYT VERACYTE INC 0.7%
Value ($000) $11,633 Shares 276,308 Est. Cost $24.40 Unrealized +65.2%
INCY INCYTE CORP 0.6%
Value ($000) $9,877 Shares 100,000 Est. Cost $79.04 Unrealized +22.4%
GLUE MONTE ROSA THERAPEUTICS INC 0.1%
Value ($000) $1,349 Shares 86,014 Est. Cost $20.37 Unrealized -33.8%
IPSC CENTURY THERAPEUTICS INC 0.1%
Value ($000) $1,222 Shares 1,228,190 Est. Cost $10.97 Unrealized -94.4%
ABSI ABSCI CORPORATION 0.2%
Value ($000) $3,397 Shares 973,260 Est. Cost $19.41 Unrealized -81.2%
TNYA TENAYA THERAPEUTICS INC 0.0%
Value ($000) $258 Shares 361,969 Est. Cost $12.86 Unrealized -89.4%
BBOT BRIDGEBIO ONCOLOGY THERAPEUT 0.2%
Value ($000) $3,535 Shares 282,312 Est. Cost $11.58 Unrealized
DNA GINKGO BIOWORKS HOLDINGS INC 0.0%
Value ($000) $303 Shares 36,493 Est. Cost $10.02 Unrealized +7.4%
RXRX RECURSION PHARMACEUTICALS IN 0.0%
Value ($000) $676 Shares 165,323 Est. Cost $6.72 Unrealized -26.3%
CTNM CONTINEUM THERAPEUTICS INC 0.1%
Value ($000) $1,695 Shares 148,333 Est. Cost $16.10 Unrealized -29.2%